Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2017 Aug 8;69(9):1400–1406. doi: 10.1002/acr.23160

Table 3.

Odds ratios for associations of clinical and behavioral variables with CPDD (n= 50,314)*

Characteristic Univariate
OR
95% CI Multivariate
OR
95% CI
Tobacco Use (ever) 0.62 0.60, 0.64 0.73 0.70, 0.76
Alcohol Abuse 0.55 0.53, 0 .58 0.62 0.58, 0.65
BMI    Underweight (<18.5) 0.75 0.66, 0.85 0.84 0.73, 0.96
   Normal (18.5–24.99) Referent Referent
   Overweight (25–29.99) 1.16 1.11,1.22 1.08 1.03, 1.14
   Obese (30–39.99) 1.12 1.07, 1.17 1.04 0.99, 1.1
   Morbidly Obese ≥40 0.88 0.81, 0.96 0.87 0.79, 0.96
Coronary Artery Disease 0.68 0.66, 0.71 0.76 0.73, 0.79
Congestive Heart Failure 0.65 0.62, 0.67 0.71 0.67, 0.75
Diabetes mellitus 0.76 0.73, 0.79 0.79 0.76, 0.83
Chronic Kidney Disease 1.08 1.04, 1.13 1.12 1,07, 1.18
Hypertension 0.7 0.67, 0.74 0.77 0.72, 0.82
Osteoarthritis 2.17 2.08, 2.26 2.26 2.15, 2.37
Gout 2.55 2.44, 2.66 2.82 2.69, 2.95
Rheumatoid Arthritis 2.07 1.93, 2.23 1.88 1.74, 2.03
Hemochromatosis 1.92 1.62, 2.26 1.87 1.57, 2.24
Osteoporosis 1.25 1.18, 1.33 1.26 1.16, 1.36
Hyperparathyroidism 2.96 2.64, 3.3 3.35 2.96, 3.79
Hypothyroidism 0.9 0.86, 0.95 0.88 0.83, 0.92
Hypomagnesemia 1.04 0.98, 1.11 1.28 1.19, 1.36
*

All characteristics, comorbidities, medications and arthroplasties listed in Table 2 were covariates in the multivariate analysis; age and sex were matched prior to analysis and not included in models.